GSK

PRÁCTICAS FCTS MANTENIMIENTOLas prácticas tendrán como finalidad:Aprender a realizar el mantenimiento correctivo y preventivo e implantación de mejoras en máquinas.Participación en instalación de nuevos equipos y puesta en marcha.Aprender a planificar y supervisar la instalación en pl

PRÁCTICAS FCTS MANTENIMIENTOLas prácticas tendrán como finalidad:Aprender a realizar el mantenimiento correctivo y preventivo e implantación de mejoras en máquinas.Participación en instalación de nuevos equipos y puesta en marcha.Aprender a planificar y supervisar la instalación en pl

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

PRÁCTICAS FCTS MANTENIMIENTOLas prácticas tendrán como finalidad:Aprender a realizar el mantenimiento correctivo y preventivo e implantación de mejoras en máquinas.Participación en instalación de nuevos equipos y puesta en marcha.Aprender a planificar y supervisar la instalación en pl

PRÁCTICAS FCTS MANTENIMIENTOLas prácticas tendrán como finalidad:Aprender a realizar el mantenimiento correctivo y preventivo e implantación de mejoras en máquinas.Participación en instalación de nuevos equipos y puesta en marcha.Aprender a planificar y supervisar la instalación en pl

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

You will join the Clinical Compliance & Improvement (CCI) team to support clinical compliance early issue detection and continuous improvement across Development Operations. You will work with colleagues in clinical teams quality and operations to gather data perform compliance monito

You will join the Clinical Compliance & Improvement (CCI) team to support clinical compliance early issue detection and continuous improvement across Development Operations. You will work with colleagues in clinical teams quality and operations to gather data perform compliance monito

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Welcome to Haleon. Were a purpose-driven world-class consumer company putting everyday health in the hands of just three years since our launch weve grown evolved and are now entering an exciting new chapter one filled with bold ambitions and enormous opportunity.Our trusted portfol

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

GSK seeks an outstanding leader in clinical development to join as VP Clinical Research Head (CRH) Nephrology within the Advanced Portfolio Unit. The Advanced Portfolio Unit works within the Respiratory Immunology and Inflammation Research Unit (RIIRU).This represents a critical and s

GSK seeks an outstanding leader in clinical development to join as VP Clinical Research Head (CRH) Nephrology within the Advanced Portfolio Unit. The Advanced Portfolio Unit works within the Respiratory Immunology and Inflammation Research Unit (RIIRU).This represents a critical and s

We manufacture and supply reliable high-quality medicines and vaccines to meet patients needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 million vaccine doses in 2024 to help make a positive

We manufacture and supply reliable high-quality medicines and vaccines to meet patients needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 million vaccine doses in 2024 to help make a positive

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Territory to include but not limited to Sacramento and the surrounding suburbs up to Chico in the north and Truckee to the east and Vacaville to the west. For more than 140 years GSK has pioneered novel research methods and technologies to help protectpeople from infectious diseases.

Territory to include but not limited to Sacramento and the surrounding suburbs up to Chico in the north and Truckee to the east and Vacaville to the west. For more than 140 years GSK has pioneered novel research methods and technologies to help protectpeople from infectious diseases.

Posting Title: Internship: Operational Quality Intern Italy 2026Requisiti formativi: Student* o Neolaureat* in materie Chimico-Farmaceutiche Economiche Ingegneristiche con forte interesse e conoscenza per lanalisi ed elaborazione dei dati.Altri requisiti: conoscenza approfondita di Ex

Posting Title: Internship: Operational Quality Intern Italy 2026Requisiti formativi: Student* o Neolaureat* in materie Chimico-Farmaceutiche Economiche Ingegneristiche con forte interesse e conoscenza per lanalisi ed elaborazione dei dati.Altri requisiti: conoscenza approfondita di Ex

Imaichi HR Site Lead / HRBPThe Site HR Lead provides HR leadership across the site enabling the delivery of the business strategy and business performance. The role will partner with the business to design and effectively execute the people strategy leveraging their local context and

Imaichi HR Site Lead / HRBPThe Site HR Lead provides HR leadership across the site enabling the delivery of the business strategy and business performance. The role will partner with the business to design and effectively execute the people strategy leveraging their local context and

Ayúdanos a adelantarnos a las enfermedades junto con nuestra Área de Marketing.Formación requerida: Actualmente cursando carreras como Marketing Administración de empresas Comunicación o relacionadas. Mínimo a 1 año para terminar.Otros requisitos: Debe estar matriculado/a en una unive

Ayúdanos a adelantarnos a las enfermedades junto con nuestra Área de Marketing.Formación requerida: Actualmente cursando carreras como Marketing Administración de empresas Comunicación o relacionadas. Mínimo a 1 año para terminar.Otros requisitos: Debe estar matriculado/a en una unive

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient

Business IntroductionGSK remains committed to achieving bold commercial ambitions for the future. By 2031 we aim to deliver 40 billion in annual sales leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patient